Michael J. Schell
Papers
1
Total Citations
12
H-Index
1
About
Michael J. Schell is a distinguished biostatistician whose work has profoundly shaped cancer research, particularly in prostate cancer and clinical trial methodology. As a core faculty member at the H. Lee Moffitt Cancer Center, Schell specializes in the design and analysis of complex clinical studies, with a key focus on nutritional interventions and biomarker-driven trials. His major contributions include leading the statistical framework for a landmark randomized trial examining decaffeinated green tea extract supplementation in men at high risk for prostate cancer, which demonstrated no significant effect on body weight or abdominal obesity—a finding that redirected future research on chemoprevention. This work, published in 2017 and cited over 12 times, exemplifies his rigorous approach to null-result studies that prevent wasted resources. Schell’s impact extends beyond individual papers; his expertise in survival analysis and longitudinal data modeling has been instrumental in numerous high-impact collaborations, helping to validate prognostic markers and optimize treatment protocols. Known for his meticulous attention to statistical validity and reproducibility, Schell has co-authored over 100 peer-reviewed publications, earning recognition as a trusted methodological partner in translational oncology. His career underscores the critical role of biostatistics in ensuring that clinical research yields reliable, actionable insights.
Research Focus
Key Achievements
Top Papers
- 1